Jan 16, 2019 -
Jan 14, 2019 - Dynavax recently presented a company outlook for 2019 at the JP Morgan Healthcare Conference. During the presentation, CEO Eddie Gray revealed encouraging HEPISLAV-B sales for Q4 of ~$3.7M.2018 was a
Jan 14, 2019 - Following precipitous revenue losses attributable to its portfolio of HCV medicines, Gilead finds itself in improving financial straits.2019 will see the release of pivotal data from Phase III clinica
Jan 11, 2019 - Lilly (LLY) is spending $8 billion to buy small cancer biotech Loxo Oncology. Big Pharma CEOs hint at spur in M&A activity in 2019.
Jan 11, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Jan 11, 2019 - Here we present four therapeutic areas whose pipeline developments are expected to garner a lot of interest in 2019.
Jan 10, 2019 - Big pharma CEOs hint at spur in M&A activity in 2019 at the 37th J.P. Morgan Healthcare Conference.
Jan 09, 2019 - After a dearth of purchase transactions across the industry, M&A has returned in a big way early in 2019 to the biotech space.Both Celgene and Loxo Oncology have been bought out for healthy premiums e
Jan 08, 2019 - Following two blockbuster merger and acquisition deals, a rise in M&A activity in the pharma space is likely led by consolidation in the cancer space.
Jan 07, 2019 - Innoviva is trading in a long-term, sustained, uptrend.The company reported strong EPS and revenue growth last quarter.Dividend reinstatement would bring back income investors.